Mono Mack Depot (Isosorbide Mononitrate)

Isosorbide Mononitrate, the active ingredient in Mono Mack Depot, is a nitrate vasodilator presented as an oral tablet for oral use. It is employed to manage angina pectoris and chronic heart failure in adult patients.

GNH USA supplies Mono Mack Depot as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable global distribution, including regulatory compliance and logistics where required.

Isosorbide Mononitrate is a nitrate vasodilator used in the management of coronary artery disease and heart failure.

- Angina pectoris: reduces the frequency and severity of chest pain episodes. - Chronic heart failure: improves exercise tolerance and alleviates dyspnoea. - Ischemic heart disease: helps maintain myocardial oxygen balance and lowers cardiac workload.

Common Side Effects: - Headache - Dizziness - Flushing - Nausea

Serious or Rare Side Effects: - Severe hypotension - Syncope - Allergic reaction (rash, angioedema)

Before initiating therapy, consider the following precautions: - Cardiovascular assessment: evaluate blood pressure and heart rate. - Blood pressure monitoring: watch for excessive drops, especially after the first dose. - Discontinuation: avoid abrupt cessation in patients with long‑term use to reduce rebound angina. - Hepatic impairment: use with caution in patients with liver dysfunction. - Elderly patients: start at the lowest effective dose and monitor closely. - Store at below 25°C: keep in the original pack, protect from moisture.

Isosorbide Mononitrate may interact with several medicines.

Major Interactions (Avoid): - Other nitrates: risk of profound hypotension. - Phosphodiesterase‑5 inhibitors (e.g., sildenafil): additive blood pressure lowering. - Guanylate cyclase stimulators: excessive vasodilation.

Moderate Interactions (Monitor Closely): - Antihypertensive agents: enhanced blood pressure reduction. - Loop diuretics: possible electrolyte disturbances. - Beta‑blockers: may mask tachycardia response.